These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

111 related items for PubMed ID: 11001240

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Imipramine vs. sertraline in panic disorder: 24-week treatment completers.
    Mavissakalian MR.
    Ann Clin Psychiatry; 2003; 15(3-4):171-80. PubMed ID: 14971862
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Clinical experiments in maintenance and discontinuation of imipramine therapy in panic disorder with agoraphobia.
    Mavissakalian M, Perel JM.
    Arch Gen Psychiatry; 1992 Apr; 49(4):318-23. PubMed ID: 1558466
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Long-term maintenance and discontinuation of imipramine therapy in panic disorder with agoraphobia.
    Mavissakalian MR, Perel JM.
    Arch Gen Psychiatry; 1999 Sep; 56(9):821-7. PubMed ID: 12884888
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Protective effects of imipramine maintenance treatment in panic disorder with agoraphobia.
    Mavissakalian M, Perel JM.
    Am J Psychiatry; 1992 Aug; 149(8):1053-7. PubMed ID: 1636805
    [Abstract] [Full Text] [Related]

  • 13. A double-blind placebo-controlled trial comparing fluvoxamine and imipramine in the treatment of panic disorder with or without agoraphobia.
    Bakish D, Hooper CL, Filteau MJ, Charbonneau Y, Fraser G, West DL, Thibaudeau C, Raine D.
    Psychopharmacol Bull; 1996 Aug; 32(1):135-41. PubMed ID: 8927663
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Imipramine treatment of panic disorder with agoraphobia: the second time around.
    Mavissakalian MR, Perel JM, de Groot C.
    J Psychiatr Res; 1993 Aug; 27(1):61-8. PubMed ID: 8515390
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. 2nd year maintenance and discontinuation of imipramine in panic disorder with agoraphobia.
    Mavissakalian MR, Perel JM.
    Ann Clin Psychiatry; 2001 Jun; 13(2):63-7. PubMed ID: 11534926
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Blood pressure and heart rate response of panic disorder patients receiving imipramine in a dose-response treatment paradigm.
    de Groot CM, Mavissakalian MR.
    J Clin Psychopharmacol; 1994 Apr; 14(2):107-10. PubMed ID: 8195450
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.